Richard Rodgers

Richard Rodgers is recorded as CEO at Opus Genetics, Inc. (IRD) since April 19, 2023 and Board Member at Opus Genetics, Inc. (IRD). The newest filing on record that lists Richard Rodgers as Board Member at Opus Genetics, Inc. (IRD) is dated March 23, 2026. Opus Genetics, Inc. reported in an 8-K filed November 1, 2023 that Richard Rodgers was terminated as Interim President and Chief Executive Officer, effective November 1, 2023. Opus Genetics, Inc. reported in an 8-K filed April 21, 2023 that Richard Rodgers was appointed interim President and Chief Executive Officer, effective April 19, 2023. The proxy statement of Opus Genetics, Inc. reports total compensation of $899,076 for Richard Rodgers in fiscal 2023, including a base salary of $379,626. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.